IXIARO
Japanese encephalitis virus, inactivated (SA14-14-2)
6 mcg / 0.5 mL · suspension · intramuscular · 2 months and older
Japanese encephalitis
Japanese encephalitis
IXIARO
Two doses, 28 days apart. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
- Products
- 1
- Dose schedules
- 1
- Guidance checked
- 2026-09-27
Authorized products
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
Before and after vaccination
- Bring your immunization record so earlier doses can be checked.
- Discuss a serious reaction to a previous vaccine, relevant health conditions, medicines and allergies before receiving a dose.
- After vaccination, stay where you can be observed for at least 15 minutes and report feeling faint or signs of an allergic reaction right away.
- Keep the vaccine name, date and dose in your immunization record.
Based on the Canadian Immunization Guide's administration practices and acute reactions guidance.
Pregnancy & breastfeeding
Pregnancy
Use if indicated for high-risk travel.
Breastfeeding
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
Japanese encephalitis (IXIARO) — two doses, 28 days apart
2 dosesTwo doses 28 days apart, from 2 months of age; finished at least 1 week before travel.
Primary series of two doses 28 days apart. Adults 18 to 65 may use an accelerated day 0 and day 7 schedule when time is short. A booster 12 to 24 months after the primary series is recommended for continued risk.
ProductsIXIARO
References and product information
- Japanese encephalitis vaccine: Canadian Immunization Guide — Chapter revised September 2023 · partial update November 2024
- Vaccine administration practices: Canadian Immunization Guide
- Anaphylaxis and other acute reactions: Canadian Immunization Guide
- Health Canada Drug Product Database — product records and monographs
- Pharmasist vaccine reference: IXIARO
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.